1. Home
  2. TNET vs SUPN Comparison

TNET vs SUPN Comparison

Compare TNET & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$62.41

Market Cap

3.0B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

BUY

Current Price

$42.63

Market Cap

2.5B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TNET
SUPN
Founded
1988
2005
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
TNET
SUPN
Price
$62.41
$42.63
Analyst Decision
Hold
Buy
Analyst Count
7
4
Target Price
★ $66.20
$61.75
AVG Volume (30 Days)
251.2K
★ 566.5K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
★ 1.81%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 3.05
N/A
Revenue
★ $5,010,000,000.00
$392,755,000.00
Revenue This Year
N/A
$23.21
Revenue Next Year
$3.80
$54.85
P/E Ratio
$20.97
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$33.67
$40.51
52 Week High
$73.08
$59.68

Technical Indicators

Market Signals
Indicator
TNET
SUPN
Relative Strength Index (RSI) 38.53 45.35
Support Level $59.61 $42.54
Resistance Level $64.37 $52.33
Average True Range (ATR) 1.87 1.40
MACD -0.44 0.12
Stochastic Oscillator 8.54 44.81

Price Performance

Historical Comparison
TNET
SUPN

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: